###begin article-title 0
BNP Signaling Is Crucial For Embryonic Stem Cell Proliferation
###end article-title 0
###begin p 1
Conceived and designed the experiments: EMA IT. Performed the experiments: EMA. Analyzed the data: EMA IT. Wrote the paper: EMA IT.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Embryonic stem (ES) cells have unlimited proliferation potential, and can differentiate into several cell types, which represent ideal sources for cell-based therapy. This high-level proliferative ability is attributed to an unusual type of cell cycle. The Signaling pathways that regulate the proliferation of ES cells are of great interest.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 739 740 739 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 28 34 <span type="species:ncbi:10090">murine</span>
###xml 270 276 <span type="species:ncbi:10090">murine</span>
In this study, we show that murine ES cells specifically express brain natriuretic peptide (BNP), and its signaling is essential for ES cell proliferation. We found that BNP and its receptor (NPR-A, natriuretic peptide receptor-A) were highly expressed in self-renewing murine ES cells, whereas the levels were markedly reduced after ES cell differentiation by the withdrawal of LIF. Targeting of BNP with short interfering RNA (siRNA) resulted in the inhibition of ES cell proliferation, as indicated by a marked reduction in the cell number and colony size, a significant reduction in DNA synthesis, and decreased numbers of cells in S phase. BNP knockdown in ES cells led to the up-regulation of gamma-aminobutyric acid receptor A (GABAAR) genes, and activation of phosphorylated histone (gamma-H2AX), which negatively affects ES cell proliferation. In addition, knockdown of BNP increased the rate of apoptosis and reduced the expression of the transcription factor Ets-1.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Appropriate BNP expression is essential for the maintenance of ES cell propagation. These findings establish BNP as a novel endogenous regulator of ES cell proliferation.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 211 214 211 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Suda1">[1]</xref>
###xml 346 349 346 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Savatier1">[2]</xref>
###xml 351 354 351 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Burdon1">[3]</xref>
Embryonic stem (ES) cells have the remarkable capacity to divide indefinitely while retaining their wide range differentiation potential, and they represent a promising source for cell transplantation therapies [1]. They exhibit a very unusual cell cycle structure, characterized by a short G1 phase and a high proportion of cells in the S phase [2], [3], which is associated with a unique mechanism of cell cycle regulation.
###end p 9
###begin p 10
###xml 112 115 112 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Minamino1">[4]</xref>
###xml 117 120 117 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Abdelalim1">[5]</xref>
###xml 206 209 206 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Abdelalim2">[6]</xref>
###xml 441 444 441 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Garbers1">[7]</xref>
###xml 546 549 546 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Koller1">[8]</xref>
###xml 644 647 644 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Garbers1">[7]</xref>
###xml 716 719 716 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Levin1">[9]</xref>
###xml 843 847 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Silberbach1">[10]</xref>
###xml 1034 1038 1034 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Abell1">[11]</xref>
###xml 1144 1148 1144 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Suda2">[12]</xref>
###xml 1241 1245 1241 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Kong1">[13]</xref>
###xml 1546 1550 1546 1550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Tamura1">[14]</xref>
###xml 1652 1656 1652 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Ogawa1">[15]</xref>
###xml 1044 1059 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1394 1398 <span type="species:ncbi:10090">mice</span>
###xml 1513 1517 <span type="species:ncbi:10090">mice</span>
###xml 1636 1642 <span type="species:ncbi:10090">murine</span>
Brain natriuretic peptide (BNP), a member of natriuretic peptide family, is produced predominately in the heart [4], [5], and recently, we have shown that BNP is expressed in ES cell-derived cardiomyocytes [6].The physiological effects of natriuretic peptides are initiated by binding to two particulate guanylate cyclase receptors; natriuretic peptide receptor type A (NPR-A), which is sensitive to ANP (atrial natriuretic peptide) and BNP [7], natriuretic peptide receptor type B (NPR-B), which is specific for CNP (c-type natriuretic peptide) [8] to produce intracellular cyclic guanosine monophosphate (cGMP) in response to hormone binding [7]. Natriuretic peptides regulate blood pressure and fluid homeostasis [9]. In addition, the abilities of natriuretic peptides to modulate cell growth and cell proliferation have received attention [10]. Cell-based studies have shown that ANP and BNP exhibit important autocrine and paracrine functions such as modulating myocyte growth, apoptosis and proliferation in smooth muscle cells [11]. BNP-transgenic mice exhibit overgrowth of the growth plate cartilage through a cGMP-dependent mechanism [12]. Furthermore, signaling through NPR-A has been found to play a pivotal role in tumor growth [13]. Although, little is known about the role of natriuretic peptides in pre-implantation embryo development, it has been reported that NPR-B-deficient mice were sterile due to lack of development of the reproductive system, and the majority (75%) of the NPR-B-deficient mice died before 100 days of age [14]. In addition, it has been found that exogenous BNP can enhance clonal propagation in murine ES cells [15], suggesting the presence of functional natriuretic peptide receptors in ES cells.
###end p 10
###begin p 11
###xml 451 452 451 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
To date, there is no data available concerning the expression of BNP in ES cells. Therefore, in the present study we have characterized the expression of BNP in undifferentiated ES cells, and examined its role in regulating ES cell proliferation. We found that BNP and its receptor NPR-A are specifically expressed in self-renewing ES cells, and the BNP signaling plays an important role in maintaining the proliferation of ES cells by inhibiting GABAAR and Ets-1 genes.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Expression of BNP and its receptors in pluripotent ES cells and pre-implantation embryos
###end title 13
###begin p 14
###xml 146 152 146 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g001">Fig. 1</xref>
###xml 218 225 218 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g001">Fig. 1A</xref>
###xml 246 253 246 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g001">Fig. 1B</xref>
###xml 283 293 283 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g001">Fig. 1C, D</xref>
###xml 316 326 316 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g001">Fig. 1E, F</xref>
###xml 583 589 583 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g001">Fig. 1</xref>
###xml 710 720 710 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g001">Fig. 1C, D</xref>
###xml 73 79 <span type="species:ncbi:10090">murine</span>
Initially, we examined the expression of BNP and its receptor, NPR-A, in murine ES cells grown under self-renewal and differentiation conditions (Fig. 1). Polymerase chain reaction with reverse transcription (RT-PCR) (Fig. 1A), Western blotting (Fig. 1B), double-immunofluorescence (Fig. 1C, D), and flow cytometry (Fig. 1E, F) analyses showed that BNP and NPR-A were highly expressed in pluripotent ES (Oct-4-positive) cells that were cultured in the presence of LIF, and that expression was down-regulated upon differentiation induced by culturing ES cells without LIF for 5 days (Fig. 1). The differentiated cells, which were negative for oct-4 expression, were also negative for BNP and NPR-A expressions (Fig. 1C, D). These results indicate that BNP and NPR-A are specifically expressed in self-renewing ES cells.
###end p 14
###begin title 15
BNP and NPR-A are expressed specifically in self-renewing ES cells.
###end title 15
###begin p 16
[A] RT-PCR analysis showing reductions in the levels of BNP and NPR-A mRNA after culture with (+) LIF in the ES cell medium or without (-) LIF for 5 days in the differentiation medium. Oct-4 and nanog were used as self-renewal markers, and beta-actin was used as a loading control. [B] Western blot showing down-regulation of the BNP protein after LIF removal in ES cells treated as in A. beta-actin was used as a loading control. [C] Double-immunofluorescence images of ES cells treated as in A, stained with antibodies against the ES cell marker Oct-4 and BNP, and counterstained with Hoechst reagent. [D] Immunofluorescence images of ES cells treated as in A, stained with antibodies against Oct-4 and NPR-A, and counterstained with Hoechst reagent. Note that the BNP and NPRA signals are down-regulated upon differentiation. [E] Flow cytometric analysis of cells treated as in A, showing the expression of BNP and Oct-4 in pluripotent ES cells and differentiated ES cells. [F] Flow cytometric analysis of cells treated as in A, showing the expression of NPR-A and Oct-4 in pluripotent ES cells and differentiated ES cells. Scale bars in C, D = 20 microm.
###end p 16
###begin p 17
###xml 444 453 444 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g002">Fig. 2A&#8211;C</xref>
###xml 97 103 <span type="species:ncbi:10090">murine</span>
To determine whether BNP, NPR-A and NPR-B are expressed in pre-implantation embryos, 3.5-day-old murine blastocysts were subjected to double-immunofluorescence analysis using anti-BNP, anti-NPR-A, or anti-NPR-B antibodies, as well as an antibody against Oct-4 (self-renewal marker). Consistent with their presence in the undifferentiated ES cells, BNP, NPR-A and NPR-B were co-expressed with the self-renewal regulator Oct-4 in the blastocyst (Fig. 2A-C). These findings suggest that BNP exerts regulatory functions prior to embryo implantation and in undifferentiated ES cells.
###end p 17
###begin title 18
BNP and its receptors are expressed in pre-implantation embryos.
###end title 18
###begin p 19
Double-immunofluorescence images of 3.5-day-old blastocysts stained with antibodies against BNP and Oct-4 [A], NPR-A and Oct-4 [B], or NPR-B and Oct-4 [C], and counterstained with Hoechst reagent. Scale bars = 20 microm.
###end p 19
###begin title 20
BNP signaling regulates ES cell proliferation
###end title 20
###begin p 21
###xml 847 854 847 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g003">Fig. 3A</xref>
###xml 947 957 947 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g003">Fig. 3B, C</xref>
###xml 1115 1125 1115 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g003">Fig. 3D, E</xref>
###xml 468 474 <span type="species:ncbi:10090">murine</span>
BNP expression in undifferentiated ES cells and repression upon differentiation suggested that it may play a role in maintaining pluripotency. We investigated this possibility by examining the effect of BNP knockdown in ES cells. A small interfering RNA (siRNA)-based technique was employed to specifically knockdown the BNP gene in undifferentiated ES cells that were maintained in a feeder-free culture. Before siRNA transfection, the undifferentiated status of the murine ES cells used for transfection was confirmed by flow cytometry and immunofluorescence (for Oct-4-positive cells). RT-PCR revealed a marked reduction in the level of BNP mRNA at 48 h post-transfection in the ES cells that were transfected with BNP-targeting siRNA (BNP siRNA), as compared with the ES cells that were transfected with a non-targeting siRNA (control siRNA) (Fig. 3A). This finding was confirmed by the reductions in protein levels observed in Western blots (Fig. 3B, C). Knockdown of BNP significantly reduced the number and colony size of the ES cells, as compared with the ES cells that were treated with the control siRNA (Fig. 3D, E).
###end p 21
###begin title 22
Knockdown of BNP suppresses ES cell proliferation.
###end title 22
###begin p 23
###xml 1015 1016 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1092 1093 1084 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 579 585 <span type="species:ncbi:10090">murine</span>
[A] RT-PCR analysis of ES cells transfected with the control siRNA or BNP siRNA, showing knockdown of the BNP gene 48 h after siRNA transfection. siRNA-mediated knockdown of BNP has no effect on the self-renewal marker genes (Oct-4 and nanog). beta-actin was used as the internal control. [B] Western blot analysis of ES cells treated as in A, showing a reduced level of BNP protein 48 h after siRNA transfection. beta-actin was used as a loading control. [C] Quantification of B (n = 3). [D] Quantification of ES cells 72 h after siRNA transfection (n = 3). [E] Morphologies of murine ES cells 48 h and 72 h after transfection with the control siRNA or BNP siRNA. [F] Flow cytometric analysis of BrdU incorporation in ES cells treated as in A. X-axis, DNA content, as shown by propidium iodide (PI) binding; y-axis, BrdU uptake after 45 min of exposure. [G] Immunofluorescence of BrdU incorporation (45 min) 48 h after transfection with the control siRNA or BNP siRNA. [H] Percentage of BrdU-positive nuclei in A (n = 30 fields). Data represent mean+/-s.d (p-value from two-tailed Student's t-test). Scale bars, 100 microm (E), 20 microm (G).
###end p 23
###begin p 24
###xml 543 550 543 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g003">Fig. 3F</xref>
###xml 748 758 748 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g003">Fig. 3G, H</xref>
To validate further the observed decrease in ES cell proliferation after BNP knockdown, siRNA-transfected cells were exposed to bromo-deoxyuridine (BrdU), and its incorporation into ES cells was quantified by immunofluorescence and flow cytometry. ES cells were examined 48 h post-transfection and following pulsed incorporation of BrdU (45 min). Flow cytometric analysis of BrdU, which was performed concurrent with the analysis of the cellular DNA content, showed a marked reduction in BrdU incorporation in ES cells treated with BNP siRNA (Fig. 3F). Likewise, we observed a significant reduction in the number of BrdU-positive cells in the BNP siRNA-treated cells, as compared to the control siRNA-treated cells, as shown by immunofluorescence (Fig. 3G, H). These results suggest that knockdown of BNP signaling has a significant effect in decreasing the rate of DNA synthesis.
###end p 24
###begin p 25
###xml 320 330 320 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g004">Fig. 4A, B</xref>
###xml 454 461 454 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g004">Fig. 4C</xref>
To assess directly the effect of BNP knockdown on the cell cycle profile, we analyzed the phases of the cell cycle 48 h after siRNA transfection. There was a significant reduction in the proportion of cells in S phase, and an increase in the proportion of cells in G1 and G2/M phases in ES cells treated with BNP siRNA (Fig. 4A, B). In contrast, there were no significant changes in the cell cycle profile of differentiated ES cells after BNP knockdown (Fig. 4C). These results suggest that inhibition of endogenous BNP suppresses DNA synthesis as a result of the reduction of the cells in the S phase in undifferentiated ES cells.
###end p 25
###begin title 26
###xml 44 50 <span type="species:ncbi:10090">murine</span>
Effect of BNP Knockdown on ES cell cycle in murine ES cells.
###end title 26
###begin p 27
[A] Cell cycle distribution of ES cells 48 h after transfection with control siRNA or BNP siRNA. [B] Percentages of cells in G1, S, and G2/M phases of cell cycle (n = 3). [C] Cell cycle analysis of differentiated ES cells (6 days without LIF), 48 h after transfection with the control siRNA or BNP siRNA show no significant difference after BNP knockdown..
###end p 27
###begin p 28
###xml 114 124 114 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g001">Fig. 1A, D</xref>
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Ogawa1">[15]</xref>
###xml 368 388 368 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005341.s001">Supplemental Fig. 1A</xref>
Furthermore, we examined the effect of exogenous BNP on ES cell proliferation. The presence of NPR-A in ES cells (Fig. 1A, D), suggests that BNP signaling can be transduced in ES cells via NPR-A. BNP addition to ES cells in low-density ES cell cultures, as previously reported [15], resulted in increased ES cell proliferation, as evidenced by the ES cell morphology (Supplemental Fig. 1A). However, the proliferative potency of exogenous BNP appeared to be lower than that of endogenously produced BNP, suggesting that the BNP/NPR-A signaling produced by ES cells masks the effect of exogenous BNP on ES cell proliferation.
###end p 28
###begin title 29
BNP knockdown and exogenous BNP have no effect on the ES cell pluripotent markers
###end title 29
###begin p 30
###xml 181 188 181 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g003">Fig. 3E</xref>
###xml 367 374 367 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g005">Fig. 5A</xref>
###xml 501 508 501 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g003">Fig. 3A</xref>
###xml 510 515 510 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g005">5B, C</xref>
###xml 578 585 578 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g003">Fig. 3A</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g005">5B</xref>
###xml 619 626 619 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g003">Fig. 3A</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g005">5C</xref>
###xml 778 786 778 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005341.s001">Fig. S1A</xref>
###xml 897 905 897 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005341.s001">Fig. S1B</xref>
###xml 1045 1051 <span type="species:ncbi:10090">murine</span>
The reduction in ES cell proliferation caused by abrogation of BNP signaling had no effect on the undifferentiated status of the ES cells, as determined by morphologic examination (Fig. 3E) and confirmed by measurements of alkaline phosphatase activity, which revealed that the levels of self-renewal in the control siRNA- and BNP siRNA-treated cells were identical (Fig. 5A). In addition, examination of the pluripotent ES cell markers Oct-4 and nanog 48 h post-transfection confirmed these results (Fig. 3A, 5B, C). Thus, ES cells treated with BNP siRNA expressed nanog mRNA (Fig. 3A, 5B) and Oct-4 mRNA and protein (Fig. 3A, 5C) at levels equivalent to those in ES cells treated with the control siRNA. Also, addition of BNP to ES cell cultures promotes ES cell propagation (Fig. S1A) without loss of pluripotent markers, as assessed by alkaline phosphatase activity 4 days after BNP addition (Fig. S1B). These findings indicate that reducing BNP does not affect ES cell pluripotent markers, and underline the role of BNP in undifferentiated murine ES cells rather than in spontaneously differentiated progeny.
###end p 30
###begin title 31
BNP knockdown does not affect on the ES cell pluripotency.
###end title 31
###begin p 32
###xml 503 504 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
[A] Alkaline phosphatase staining of ES cells 4 days after transfection with control siRNA or BNP siRNA. [B] Real-time PCR analysis shows equal level of nanog mRNA (pluripotent marker) in ES cells 48 h after siRNA transfection with control siRNA or BNP siRNA (n = 3). [C] Flow cytometric analysis of Oct-4 expression (a marker of pluripotency) in ES cells treated as in A, shows no significant difference in Oct-4 levels after BNP knockdown. Data represent mean+/-s.d (p-value from two-tailed Student's t-test). Scale bars, 10 microm (F).
###end p 32
###begin title 33
BNP knockdown suppresses cGMP production and NPR-B mRNA
###end title 33
###begin p 34
###xml 306 313 306 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g006">Fig. 6A</xref>
###xml 671 678 671 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g006">Fig. 6B</xref>
In addition, we measured the intracellular levels of cGMP, to determine whether the cGMP pathway is involved in the effects of BNP knockdown on ES cells. The levels of cGMP were reduced significantly in ES cells treated with BNP siRNA, as compared to the levels in ES cells treated with the control siRNA (Fig. 6A). It is known that the natriuretic peptides -induced cGMP production is mainly due to the activation of NPR-A and/or NPR-B. Examination of NPR-A and NPR-B genes showed that NPR-B mRNA was markedly reduced in ES cells treated with BNP siRNA, as compared to the ES cells treated with the control siRNA, and no change was observed in the levels of NPR-A mRNA (Fig. 6B). These results suggest that the cGMP reduction was mainly due to the suppression of NPR-B gene.
###end p 34
###begin title 35
siRNA-mediated knockdown of BNP reduces cGMP production and NPR-B mRNA.
###end title 35
###begin p 36
###xml 270 271 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
[A] cGMP assay of ES cells 48 h after ES cell transfection with the control siRNA or BNP siRNA. [B] PCR analysis of NPR-A and NPR-B 48 h after ES cell transfection with the control siRNA or BNP siRNA . Data represent mean+/-s.d (n = 3; p-value from two-tailed Student's t-test).
###end p 36
###begin title 37
###xml 44 45 44 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
Knockdown of BNP signaling up-regulates GABAAR genes
###end title 37
###begin p 38
###xml 155 156 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 236 237 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 299 300 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 348 355 341 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g007">Fig. 7A</xref>
To elucidate the mechanisms underlying the effects of BNP signaling on ES cell proliferation, we used Real-Time PCR to analyze the expression level of GABAAR 48 h after siRNA transfection. We found that the expression levels of the GABAAR alpha1 and beta3 subunits, which are the major units of GABAAR in ES cells, were significantly up-regulated (Fig. 7A) in response to the suppression of BNP in ES cells.
###end p 38
###begin title 39
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 85 91 <span type="species:ncbi:10090">murine</span>
BNP knockdown upregulates GABAAR genes, induces apoptosis and downregulates Ets-1 in murine ES cells.
###end title 39
###begin p 40
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 76 77 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 761 762 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 778 779 760 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 1091 1092 1071 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
[A] Real-time PCR analysis of the mRNA levels for the GABAAR alpha1 and GABAAR beta3 subunits 48 h after ES cell transfection with the control siRNA or BNP siRNA. [B] ES cells treated as in A were analyzed by Western blotting using the anti-gamma-H2AX antibody. beta-actin is shown as a control for loading. [C] Immunofluorescence analysis shows the distribution of gamma-H2AX foci (green) in ES cells treated as in A and B. DNA was counterstained with Hoechst reagent (blue). [D] PCR analysis of ES cells for BNP expression after 24 h of exposure to muscimol. [E] Western blot analysis of BNP in ES cells treated as in D. [F] Apoptosis assay 48 h after transfection with control siRNA or BNP siRNA. Flow cytometry profile represents Annexin-V-FITC staining in x axis and PI in y axis. The number represents the percentage of early apoptotic cells in each condition (lower right quadrant) (n = 2; p-value = 0.016). [G] PCR analysis of Ets-1 mRNA 48h and 72 h after ES cell transfection with the control siRNA or BNP siRNA. Data represent mean+/-s.d (n = 3; p-value from two-tailed Student's t-test).
###end p 40
###begin p 41
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 164 168 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Andang1">[16]</xref>
###xml 263 264 255 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 399 406 387 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g007">Fig. 7B</xref>
###xml 533 540 517 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g007">Fig. 7C</xref>
To determine whether the elevated levels of the GABAAR subunits in BNP-knockdown ES cells are associated with the activation of gamma-H2AX, as previously described [16], we examined the level of gamma-H2AX by Western blotting. As expected for the presence of GABAAR up-regulation, gamma-H2AX was expressed more abundantly in ES cells treated with BNP siRNA than in those treated with control siRNA (Fig. 7B). Furthermore, immunofluorescence analysis revealed the accumulation of gamma-H2AX nuclear foci in response to BNP knockdown (Fig. 7C).
###end p 41
###begin p 42
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 139 146 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g007">Fig. 7D</xref>
###xml 161 168 161 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g007">Fig. 7E</xref>
###xml 306 307 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
Furthermore, activation of endogenous GABAAR with muscimol (a GABAAR agonist) in low-density cultures, significantly reduced the BNP mRNA (Fig. 7D) and protein (Fig. 7E) levels, which are associated with reductions in ES cell proliferation, suggesting a regulatory mechanism between endogenous BNP and GABAAR signaling for the control of ES cell proliferation.
###end p 42
###begin title 43
Knockdown of BNP signaling induces apoptosis and down-regulates Ets-1
###end title 43
###begin p 44
###xml 447 454 447 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g007">Fig. 7F</xref>
###xml 573 574 573 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 869 873 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Lianguzova1">[17]</xref>
###xml 873 874 873 874 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 889 899 889 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005341.s002">Fig. S2A&#8211;B</xref>
###xml 921 929 921 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005341.s002">Fig. S2C</xref>
###xml 1302 1309 1302 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g007">Fig. 7G</xref>
The reduced cell numbers and colony size that we observed in ES cells after BNP knockdown could be caused by increased cell death and/or decreased cell proliferation. Therefore, the apoptosis assay was performed using Annexin V as a marker for apoptotic cells. Flow cytometric analysis showed that the percentage of cells undergoing apoptosis significantly increased in the BNP siRNA-treated cells, as compared to the control siRNA-treated cells (Fig. 7F). These data indicate that BNP plays an important role in maintaining ES cell survival. However, it is known that GABAAR activation does not cause apoptosis or DNA damage in ES cells. Therefore, we examined the phosphoinositide 3-kinase (PI3K) pathway, which is known to be involved in proliferation and growth of ES cells by stimulating the G1-S phase transition, and its inhibition induces apoptosis in ES cells [17]. Western blot (Fig. S2A-B) and flow cytometry (Fig. S2C) analyses revealed no change in the level of phospho-Akt (ser 473), a marker for PI3K, suggesting that BNP signaling does not interfere with PI3K pathway. Furthermore, we examined the mRNA levels of the transcription factor Ets-1, which is required for normal survival of cells. Using RT-PCR, we found that the expression levels of the Ets-1 significantly down-regulated (Fig. 7G) at 48 h and 72 h from transfection in ES cells treated with BNP siRNA, indicating that BNP is required for the activation of Ets-1 in ES cells.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 77 83 <span type="species:ncbi:10090">murine</span>
###xml 174 180 <span type="species:ncbi:10090">murine</span>
###xml 377 383 <span type="species:ncbi:10090">murine</span>
In the present study we demonstrate for the first time that undifferentiated murine ES cells express BNP and its receptor. We also report that BNP signaling is essential for murine ES cell survival and their clonal growth, through the suppression of GABAAR genes and activation of the transcription factor Ets-1. Together, these findings establish BNP as a novel regulator for murine ES cell proliferation.
###end p 46
###begin p 47
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Nichols1">[18]</xref>
The results showed that the expression of BNP and NPR-A were observed only in Oct-4-positive cells in the undifferentiated ES cells and the pre-implantation embryos. These results establish definitively that BNP and NPR-A are specifically expressed in self-renewing ES cells. During development, Oct-4 expression is required to maintain the pluripotent cell population of the inner cell mass (ICM) and epiblast. In addition, Oct-4 is highly expressed in ES cells, and without this factor, these cells differentiate along the trophoblast lineage [18].These findings suggest that BNP may exert regulatory functions prior to embryo implantation and in undifferentiated ES cells. Therefore, we investigated this possibility by examining the effect of BNP knockdown in ES cells, which significantly suppressed ES cell proliferation by decreasing the percentage of cells in S phase (DNA synthesis phase) and accumulation of cells in G1 and G2/M phases. The mechanism underlying the accumulation of cells in G2/M cell cycle phases is unknown, which suggest that BNP may has a role in regulating G2/M cell cycle transition, as well as G1/S in ES cells. These findings suggest the important role of endogenous BNP in maintaining the ES cell proliferation.
###end p 47
###begin p 48
###xml 43 47 43 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Suda2">[12]</xref>
###xml 49 53 49 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Ogawa1">[15]</xref>
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Suda2">[12]</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Steinhelper1">[19]</xref>
###xml 531 534 531 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Koller1">[8]</xref>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Suga1">[20]</xref>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Tamura2">[21]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Hohn1">[22]</xref>
###xml 756 760 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Tamura2">[21]</xref>
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
###xml 176 181 <span type="species:ncbi:10090">mouse</span>
###xml 397 412 <span type="species:ncbi:10090">transgenic mice</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">Mice</span>
BNP is known to play a role in cell growth [12], [15]. A transgenic mouse over-expressing BNP exhibited marked skeletal overgrowth, and studies using in vitro organ culture of mouse tibia demonstrated that BNP increases cGMP production and activates the proliferation of growth plate chondrocytes via GC-coupled natriuretic peptide receptors [12]. In contrast, no skeletal defects are reported in transgenic mice overexpressing ANP [19], although ANP and BNP have similar affinity to known GC-coupled natriuretic peptide receptors [8], [20]. It is interesting to note mice with targeted deletion of BNP [21] exhibit a different phenotype than ANP-deficient mice [22]. Mice without BNP do not have hypertension; instead they show focal ventricular fibrosis [21]. This had led to the speculation that there may be a separate unknown receptor for BNP in cardiac fibroblasts.
###end p 48
###begin p 49
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Yasoda1">[23]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Oliver1">[24]</xref>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Tamura1">[14]</xref>
###xml 1222 1226 1222 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Schulz1">[25]</xref>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 156 160 <span type="species:ncbi:10090">Mice</span>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
However, in cultures of embryonic mouse tibias, BNP and CNP increased bone growth and stimulated cGMP production by signaling through NPR-B [23]. Moreover, Mice lacking NPR-A exhibit cardiac hypertrophy, hypertension, fibrosis [24]. These findings agree with our results, which showed that BNP knockdown in ES cells led to a marked decrease in intracellular cGMP level and a significant reduction in mRNA level of NPR-B. It is possible that the reduced cGMP level in ES cells is a reflection of the reduced NPR-B mRNA level. This hypothesis represents the signaling pathway through NPR-B as a possible regulator for ES cell proliferation. However, further studies are needed to elucidate the role of NPR-B in ES cell proliferation. It has been reported that mice lacking NPR-B were sterile due to lack of development of the reproductive system [14]. Furthermore, in the current study NPR-B expression was detected in Oct-4-positive cells of the pre-implantation embryos, suggesting a role of NPR-B in early stages of development. Taken together, these findings suggest that BNP could be exerting its proliferative effects through either NPR-A, its preferred receptor or through NPR-B, for which it has reasonable affinity [25].
###end p 49
###begin p 50
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 73 74 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 225 226 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 359 363 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Lianguzova1">[17]</xref>
###xml 410 411 399 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 472 473 461 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 509 513 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Yu1">[26]</xref>
###xml 604 605 593 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
BNP knockdown led to up-regulation of GABAAR genes. Furthermore, the GABAAR activation led to suppression of BNP expression in ES cells. Recently, the alpha1 and beta3 subunits have been found to be the major subunits of GABAARs in ES cells, and they negatively regulate ES cell proliferation through a phosphorylated histone (gamma-H2AX)-dependent mechanism [17]. However, the correlation between BNP and GABAAR has been previously determined, whereby BNP suppresses GABAAR currents in retinal bipolar cells [26]. These findings suggest that endogenous BNP signaling is important for inhibiting the GABAAR levels in ES cells, which in turn promotes ES cell proliferation.
###end p 50
###begin p 51
###xml 156 160 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Celeste1">[27]</xref>
###xml 184 185 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 288 292 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Andang1">[16]</xref>
###xml 294 298 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Ichijima1">[28]</xref>
###xml 544 545 536 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
Also, we found that BNP knockdown led to accumulation of gamma-H2AX in ES cells. H2AX is considered to be critical for the surveillance of genome integrity [27]. It was found that GABAAR activation led to phosphorylation of H2AX in cell cycle-dependent and DNA damage-independent manners [16], [28]. However, our results showed an increase in the rate of apoptosis in the BNP siRNA-treated cells. Taken together, these findings suggest that accumulation of gamma-H2AX after BNP knockdown in ES cells may be as a result of the activation of GABAARs and/or apoptosis.
###end p 51
###begin p 52
###xml 163 166 163 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Bories1">[29]</xref>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Muthusamy1">[30]</xref>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Pikkarainen1">[31]</xref>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Kumar1">[32]</xref>
BNP knockdown in ES cells led to a marked reduction in the transcription factor Ets-1. Ets-1 was shown to be required for the normal survival of T cells, and Ets-1-/- T cells displayed a severe proliferative defect and demonstrated increased rates of spontaneous apoptosis, indicating anti-apoptotic role [29], [30]. In addition, Ets-1 was reported to participate in the activation of BNP gene [31]. Furthermore, NPR-A gene transcription and guanylyl cyclase (GC) activity of the receptor are critically regulated by Ets-1 in target cells [32]. Although, there is no data available about the role of Ets-1 in ES cell proliferation, these results indicate that the Ets-1 may be involved in the anti-apoptotic and proliferative effects of endogenous BNP on ES cells.
###end p 52
###begin p 53
###xml 395 396 395 396 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 477 483 473 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g008">Fig. 8</xref>
###xml 554 555 550 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 599 605 595 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005341-g008">Fig. 8</xref>
###xml 86 92 <span type="species:ncbi:10090">murine</span>
In summary, our data establish BNP as an essential regulator for the proliferation of murine ES cells. The undifferentiated ES cells express high levels of BNP and its specific receptor. Knockdown of BNP in ES cells led to a marked decrease in ES cell proliferation through a cGMP-dependent mechanism. The reduction of ES cell number observed in BNP siRNA-treated cells was primarily due to GABAAR activation, gamma-H2AX accumulation, Ets-1 inhibition and apoptosis induction (Fig. 8). The present study defines a new pathway that is mediated by BNP-GABAAR for control ES cell propagation in vitro (Fig. 8). These findings will facilitate our understanding of the signaling pathways that maintain the unusual proliferative characteristics of ES cells.
###end p 53
###begin title 54
Proposed model of BNP-mediated maintenance of ES cell proliferation.
###end title 54
###begin p 55
###xml 19 20 19 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 178 179 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
BNP suppresses GABAAR, which in turn suppresses the phosphorylation of H2AX into gamma-H2AX. As a result, activation of ES cell proliferation occurs. Also, the activation of GABAAR leads to suppression of BNP. In other pathways, BNP activates NPR-B and Ets-1, which may enhance the proliferation and survival of ES cells.
###end p 55
###begin title 56
Materials and Methods
###end title 56
###begin title 57
ES Cell Culture
###end title 57
###begin p 58
###xml 746 750 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Singh1">[33]</xref>
###xml 804 808 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Andang1">[16]</xref>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 518 524 <span type="species:ncbi:10090">Murine</span>
###xml 752 758 <span type="species:ncbi:10090">Murine</span>
Murine ES cells (E14TG2a) (CRL-1821; American Type Culture Collection, Manassas, VA, USA) were maintained in DMEM/F-12 medium (Sigma) that was supplemented with 1000 U/ml LIF (Chemicon), 11% FBS, 2 mM glutamine (Nacalai Tesque, Japan), 1 mM sodium pyruvate (Sigma), 1% MEM nonessential amino acids (GIBCO), 0.1 mM 2-mercaptoethanol (Sigma) and 1% penicillin-streptomycin. For siRNA transfection, ES cells were cultured in the same medium, except that FBS was replaced with 15% Knockout Serum Replacement (KSR; GIBCO). Murine ES cells were cultured under feeder-free conditions in the presence of LIF. For differentiation, embryoid bodies were grown in bacteriologic dishes without LIF and beta-mercaptoethanol for 5 days, as described previously [33]. Murine BNP (American Peptide) and muscimol (Tocris) [16] were added at 1 microM and 100 microM, respectively, to the cultured ES cells, while the control cells received vehicle alone.
###end p 58
###begin title 59
Immunofluorescence
###end title 59
###begin p 60
###xml 180 184 <span type="species:ncbi:10090">mice</span>
ES cells grown on glass coverslips were rinsed briefly with PBS and fixed for 20 min in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Blastocysts were collected from ICR mice at 3.5 dpc and fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). All experimental procedures and protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the Shiga University of Medical Science, Otsu, Japan and conformed to the NIH Guide for the Care and Use of Laboratory Animals.
###end p 60
###begin p 61
###xml 517 522 <span type="species:ncbi:10090">mouse</span>
###xml 615 620 <span type="species:ncbi:10090">mouse</span>
###xml 659 665 <span type="species:ncbi:9986">rabbit</span>
The ES cells and blastocysts were permeabilized for 10 min with 0.1% Triton X-100 in PBS, and blocked for 40 min with 4% BSA in PBS at room temperature (RT). They were then incubated at 4degreesC overnight with the following antibodies; anti-BNP (1:1000; Chemicon), anti-NPR-A (1:300; Abcam), anti-NPR-B (1:200, Abcam), anti-Oct-4 (1:200, sc-5279; Santa Cruz Biotechnology), and anti-gamma-H2AX IgG (1: 500; Upstate). This was followed by incubation with the following secondary antibodies; Chromeo 546-labelled anti-mouse IgG (1:1000; Active Motif Chromeon GmbH, Tegernheim, Germany), Alexa Fluor 488-labeled anti-mouse IgG, and Alexa Fluor 488-labeled anti-rabbit IgG (1:500; Molecular Probes). Nuclei were counterstained with Hoechst 33342 (1 microg/ml) (Invitrogen). The slides were examined by confocal laser microscopy (C1si; Nikon, Japan) and the images were processed using the Nikon EZ-C1 viewer software.
###end p 61
###begin p 62
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005341-Heo1">[34]</xref>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
Immunofluorescence analysis of BrdU incorporation was performed as described previously [34]. BrdU (1:100; Invitrogen) was added to the culture medium 48 h after transfection, and the incubation was continued for an additional 45 min. Cells were incubated with Alexa Fluor 488-conjugated mouse anti-BrdU antibody (1:200; Molecular Probes) in 2% BSA-PBS overnight at 4degreesC. The percentage of BrdU-positive nuclei relative to the total number of nuclei per field of vision was determined. A minimum of five fields of vision per coverslip was counted.
###end p 62
###begin title 63
Reverse Transcription-Polymerase Chain Reaction (PCR) and Real-Time PCR
###end title 63
###begin p 64
Total RNA was extracted using the RNeasy Mini kit (Qiagen) according to the manufacturer's instructions. cDNA synthesis was performed with 1 microg of total RNA using the Superscript III first-stand cDNA synthesis kit (Invitrogen). The cDNA (0.5 microg) was used as a template in a mixture that contained Ampli Taq Gold polymerase (Applied Biosystems). RT-PCR was performed with an annealing temperature of 58degreesC.
###end p 64
###begin p 65
The cDNA samples were analyzed by Real-Time PCR in a LightCycler Real-Time PCR system (Roche Diagnostics) using the SYBR Premix Ex Taq II (Takara, Japan). Standard curves were generated for each Real-Time PCR run using serial 5-fold dilutions of samples that contained the gene of interest. Following PCR, the specificities and identities of the RT-PCR products were verified using melting curve analysis; this analysis distinguished specific PCR products from non-specific PCR products that arose from primer-dimer formation. The reactions were carried out in triplicates. The relative mRNA levels were determined from the appropriate standard curves and corrected for the beta-actin mRNA levels.
###end p 65
###begin p 66
###xml 65 92 65 92 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGAAGGTGCTGTCCCAGATG-3&#8242;</named-content>
###xml 97 122 97 122 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GACGGATCCGATCCGGTC-3&#8242;</named-content>
###xml 131 157 131 157 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTACGCCAACAACCTGGAG-3&#8242;</named-content>
###xml 164 187 164 187 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AAGAGCTGTAAAGCCCACGA-3&#8242;</named-content>
###xml 196 220 196 220 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGATGCTGTGAGCCAAGG-3&#8242;</named-content>
###xml 226 257 226 257 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAACAAAATGATGAGTGACAGACAG-3&#8242;</named-content>
###xml 267 293 267 293 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACCCACCCATGCTAGTCTT-3&#8242;</named-content>
###xml 298 324 298 324 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACCCTCAAACTCCTGGTCCT-3&#8242;</named-content>
###xml 334 360 334 360 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATATCAGGTTAATGGAGCC-3&#8242;</named-content>
###xml 365 391 365 391 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTAGTCGAAGCTGTCATAGG-3&#8242;</named-content>
###xml 398 399 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 409 437 405 433 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTTGGGAGAGCGTGTAACTGAA-3&#8242;</named-content>
###xml 442 472 438 468 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACTCCATATCGTGGTCTGAAACTG-3&#8242;</named-content>
###xml 478 479 474 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 488 518 481 511 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATCAAAATCCCTGATCTAACCGA-3&#8242;</named-content>
###xml 523 554 516 547 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGAGAGAAAAGGTGAATGGAAACA-3&#8242;</named-content>
###xml 563 589 556 582 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCATGACAGCCCATGGGAAA-3&#8242;</named-content>
###xml 594 620 587 613 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGTGACAATGCAGATGTTGG-3&#8242;</named-content>
###xml 634 665 624 655 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGGTGGGCATGGGTCAGAAGGATTC-3&#8242;</named-content>
###xml 670 701 660 691 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATGGCTGGGGTGTTGAAGGTCTCA-3&#8242;</named-content>
The primer sequences (forward and reverse) were as follows: BNP, 5'-CTGAAGGTGCTGTCCCAGATG-3' and 5'- GACGGATCCGATCCGGTC-3'; NPR-A, 5'-AGTACGCCAACAACCTGGAG-3' , and AAGAGCTGTAAAGCCCACGA-3'; Oct-4, 5'-GGATGCTGTGAGCCAAGG-3', and 5'-GAACAAAATGATGAGTGACAGACAG-3' ; Nanog, 5'-CACCCACCCATGCTAGTCTT-3' and 5'-ACCCTCAAACTCCTGGTCCT-3' ; Ets-1, 5'-CATATCAGGTTAATGGAGCC-3' and 5'-GTAGTCGAAGCTGTCATAGG-3' ; GABAAR alpha1, 5'-TTTGGGAGAGCGTGTAACTGAA-3' and 5'-ACTCCATATCGTGGTCTGAAACTG-3'; GABAAR beta3, 5'-AATCAAAATCCCTGATCTAACCGA-3' and 5'-AAGAGAGAAAAGGTGAATGGAAACA-3'; NPR-B, 5'-TCATGACAGCCCATGGGAAA-3' and 5'-GGTGACAATGCAGATGTTGG-3'; beta-actin, 5'-TGGTGGGCATGGGTCAGAAGGATTC-3' and 5'-CATGGCTGGGGTGTTGAAGGTCTCA-3'.
###end p 66
###begin title 67
RNA Interference
###end title 67
###begin p 68
###xml 20 26 <span type="species:ncbi:10090">murine</span>
###xml 403 406 <span type="species:ncbi:9685">Cat</span>
RNA interference in murine ES cells was carried out according to the manufacturer's protocol using Lipofectamine 2000 (Invitrogen) in 6-well plates. Two pairs of siRNAs (Invitrogen) were designed for BNP (NM_008726) using the BLOCK-iT RNAi Designer software. BNP siRNA1 gave higher level of BNP knockdown and therefore used for all subsequent experiments. The appropriate siRNA negative control Duplex (Cat. No. 12935-300; Invitrogen) was selected based on the percentage G/C. The BNP siRNA and control siRNA were transfected at a final concentration of 40 microM for 24 h in triplicate for each treatment. At 48 h post-transfection, BNP knockdown was confirmed by RT-PCR and Western blotting. The sequences of BNP siRNAs were as follows:
###end p 68
###begin p 69
###xml 19 46 19 46 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCCAGAGACAGCUCUUGAATT-3&#8242;</named-content>
###xml 59 87 59 87 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- UUCAAGAGCUGUCUCUGGGTT-3&#8242;</named-content>
BNP siRNA1: sense, 5'-CCCAGAGACAGCUCUUGAATT-3'; antisense, 5'- UUCAAGAGCUGUCUCUGGGTT-3'.
###end p 69
###begin p 70
###xml 19 46 19 46 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGCACAAGAUAGACCGGAUTT-3&#8242;</named-content>
###xml 59 87 59 87 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AUCCGGUCUAUCUUGUGCCTT-3&#8242;</named-content>
BNP siRNA2: sense, 5'-GGCACAAGAUAGACCGGAUTT-3'; antisense, 5'- AUCCGGUCUAUCUUGUGCCTT-3'.
###end p 70
###begin title 71
Western Blotting
###end title 71
###begin p 72
###xml 418 424 <span type="species:ncbi:9986">rabbit</span>
###xml 455 460 <span type="species:ncbi:10090">mouse</span>
Total protein extracts were prepared from ES cells, dissolved in SDS-PAGE buffer, and transferred to nitrocellulose membranes (Amersham Biosciences, Germany). Proteins were detected using antibodies against BNP (1:2000; Chemicon), gamma-H2AX (1: 1000; Upstate), phospho-Akt (Ser 473) (1: 1000, Cell Signaling), and beta-actin (1:6000, sc-47778; Santa Cruz Biotechnology). The secondary antibodies were: Histofine anti-rabbit IgG complex or Histofine anti-mouse IgG complex (1:50; Nichirei, Japan). The blots were developed using the SuperSignal West Pico Chemiluminescent substrate (Pierce), and visualized using a LAS-3000 FujiFilm Lumino-Image Analyzer (FujiFilm, Tokyo, Japan).
###end p 72
###begin title 73
Flow Cytometry
###end title 73
###begin p 74
###xml 537 543 <span type="species:ncbi:9986">rabbit</span>
###xml 592 597 <span type="species:ncbi:10090">mouse</span>
Cells were fixed in 4% paraformaldehyde for 15 min at RT, and washed with PBS that contained 2% FBS. Cells were incubated for 3 min in 100% ethanol, and blocked in 2% BSA for 20 min at RT. For staining for Oct-4 or double-labeling for BNP and Oct-4 or NPR-A and Oct-4, the cells were incubated for 1 h on ice with the following primary antibodies: anti-BNP (1:1000; Chemicon); anti-NPR-A (1:200; Abcam); and anti-Oct-4 (1:200; Santa Cruz Biotechnology). This was followed by incubation for 1 h at RT with Alexa Fluor 488-conjugated anti-rabbit antibody and/or Alexa Fluor 647-conjugated anti-mouse antibody (1:200; Molecular Probes). Data acquisition was performed using a FACSCalibur (BD Biosciences) and the data were analyzed using the CellQuest program. At least 10,000 events were collected for each sample.
###end p 74
###begin title 75
Cell cycle analysis
###end title 75
###begin p 76
The cells were fixed overnight in 70% ethanol at 4degreesC. Enzymatic removal of RNA was carried out using 100 microg/ml RNase (Boehringer Mannheim GmbH, Mannheim, Germany) at RT for 20 min. The cells were then stained with 5 microg/ml propidium iodide (PI; Sigma) at 4degreesC for 40 min. Flow cytometric analysis was carried out on 20,000 gated events. The cell cycle phase distribution was analyzed using the MODFIT-LT Flow Cytometry Modeling Software (Verity Software House).
###end p 76
###begin title 77
Bromodeoxyuridine (BrdU) incorporation
###end title 77
###begin p 78
###xml 526 531 <span type="species:ncbi:10090">mouse</span>
The level of BrdU incorporation was measured together with the DNA content. ES cells 48 h after siRNA transfection were pulsed (45 min) with BrdU (1:100; Invitrogen). ES cells were dispersed into single cells; the cells were fixed overnight in 70% ethanol at 4degreesC. DNA denaturation was subsequently performed by incubation in 1 N HCl for 20 min at room temperature. The cells then washed and incubated with 0.1 M sodium tetraborate for 10 min at room temperature. The cells were incubated with Alexa Fluor 488-conjugated mouse anti-BrdU antibody (1:100; Molecular Probes) in 2% BSA-PBS for 2 h at 4degreesC. The cells were then incubated with 100 microg/ml RNase (Boehringer Mannheim) for 15 min, followed by 40 min of incubation in freshly prepared PI (5 microg/ml).At least 10,000 cells events were recorded for each sample using a FACSCalibur (BD Biosciences) and analyzed using the CellQuest program. The samples were subjected to two-parameter dot plot histogram analysis (BrdU incorporation vs. DNA content).
###end p 78
###begin title 79
Alkaline Phosphatase (ALP) Activity Assay
###end title 79
###begin p 80
Staining for alkaline phosphatase (ALP) was performed at room temperature using an alkaline phosphatase kit (Chemicon), according to the manufacturer's instructions. During reaction, culture dishes were protected from drying and direct light. Images were observed under an inverted microscope (Nikon, Japan).
###end p 80
###begin title 81
Cell Proliferation Assay
###end title 81
###begin p 82
In order to determine the number of cells, the cells were washed with PBS and trypsinized from the culture dishes. The cell suspension was mixed with trypan blue solution, and the number of live cells was determined using a homocytometer. Cells failing to exclude the dye were considered nonviable.
###end p 82
###begin title 83
Apoptosis Assay
###end title 83
###begin p 84
###xml 437 438 425 426 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
Annexin V/propidium iodide (PI) staining was performed using flow cyometry according to the manufacturer's guidelines (MBL, USA). Briefly, ES cells were washed in ice-cold PBS. The cells were then resuspended in 500 microl of binding buffer and incubated with 5 microl of Annexin V-EGFP and 5 microl of PI for 10 min in the dark at room temperature. Flow cytometric analysis was immediately performed using a FACSCalibur (BD Biosciences).
###end p 84
###begin title 85
Intracellular cGMP Assay
###end title 85
###begin p 86
Cells were lyzed with 0.1 M HCl containing 0.1% Triton X-100 at RT for 20 min. The lysates were centrifuged, and the levels of cGMP in the supernatants were measured with a cGMP enzyme immunoassay kit (Assay Designs).
###end p 86
###begin title 87
Statistical Analysis
###end title 87
###begin p 88
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
The results are expressed as mean s.d., as indicated in the figure legends. Statistical significance was determined using the paired Student's t-test.
###end p 88
###begin title 89
Supporting Information
###end title 89
###begin p 90
Exogenous BNP enhances ES cell proliferation without affecting ES cell pluripotency. [A] ES cell colonies 3 days after exposure to BNP. ES cells were supplemented with 1 microM BNP daily for 3 days in low-density cell cultures. [B] The alkaline phosphatase activities of the ES cells were measured after 4 days in the presence or absence of 1 microM BNP. Scale bars: A, 100 microm; B, 10 microm.
###end p 90
###begin p 91
(0.08 MB PDF)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
Effect of BNP signaling on phosphoinositide 3-kinase (PI3K). [A] Western blot analysis for phosphor-Akt (Ser 473) 48 h after siRNA transfection. [B] Western blot analysis for phosphor-Akt (Ser 473) after 24 h exposure to BNP (1 microM). [C] Flow cytometric analysis of phosphor-Akt (Ser 473) 48 h after siRNA transfection.
###end p 93
###begin p 94
(0.16 MB PDF)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
We thank Dr. A. Matsuo for advice on Real-Time PCR, T. Yamamoto for help with confocal microscopy, and Y. Mori for assistance with flow cytometry.
###end p 96
###begin title 97
References
###end title 97
###begin article-title 98
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse embryonic stem cells exhibit indefinite proliferative potential.
###end article-title 98
###begin article-title 99
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts.
###end article-title 99
###begin article-title 100
Signalling, cell cycle and pluripotency in embryonic stem cells.
###end article-title 100
###begin article-title 101
The presence of brain natriuretic peptide of 12,000 daltons in porcine heart.
###end article-title 101
###begin article-title 102
Molecular cloning of BNP from heart and its immunohistochemical localization in the hypothalamus of monkey.
###end article-title 102
###begin article-title 103
In vitro expression of natriuretic peptides in cardiomyocytes differentiated from monkey embryonic stem cells.
###end article-title 103
###begin article-title 104
Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands.
###end article-title 104
###begin article-title 105
Selective activation of the B natriuretic peptide receptor by c-type natriuretic peptide (CNP).
###end article-title 105
###begin article-title 106
Natriuretic peptides.
###end article-title 106
###begin article-title 107
Natriuretic peptide signaling: molecular and cellular pathways to growth regulation.
###end article-title 107
###begin article-title 108
Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor,
###end article-title 108
###begin article-title 109
###xml 23 38 <span type="species:ncbi:10090">transgenic mice</span>
Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide.
###end article-title 109
###begin article-title 110
Natriuretic peptide receptor a as a novel anticancer target.
###end article-title 110
###begin article-title 111
Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.
###end article-title 111
###begin article-title 112
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
A novel mechanism for regulating clonal propagation of mouse ES cells.
###end article-title 112
###begin article-title 113
###xml 27 28 27 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
Histone H2AX-dependent GABAA receptor regulation of stem cell proliferation.
###end article-title 113
###begin article-title 114
###xml 98 104 <span type="species:ncbi:10090">murine</span>
Phosphoinositide 3-kinase inhibitor LY294002 but not serum withdrawal suppresses proliferation of murine embryonic stem cells.
###end article-title 114
###begin article-title 115
Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4.
###end article-title 115
###begin article-title 116
###xml 15 30 <span type="species:ncbi:10090">transgenic mice</span>
Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes.
###end article-title 116
###begin article-title 117
Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.
###end article-title 117
###begin article-title 118
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Cardiac fibrosis in mice lacking brain natriuretic peptide.
###end article-title 118
###begin article-title 119
Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.
###end article-title 119
###begin article-title 120
Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway.
###end article-title 120
###begin article-title 121
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.
###end article-title 121
###begin article-title 122
C-type natriuretic peptide and guanylyl cyclase B receptor.
###end article-title 122
###begin article-title 123
Modulation by brain natriuretic peptide of GABA receptors on retinal ON-type bipolar cells.
###end article-title 123
###begin article-title 124
H2AX haploinsufficiency modifies genomic stability and tumor susceptibility.
###end article-title 124
###begin article-title 125
###xml 46 51 <span type="species:ncbi:9606">human</span>
Phosphorylation of histone H2AX at M phase in human cells without DNA damage response.
###end article-title 125
###begin article-title 126
Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 pro-oncogene.
###end article-title 126
###begin article-title 127
Defective activation and survival of T cells lacking the Ets-1 transcription factor.
###end article-title 127
###begin article-title 128
Endothelin-1-specific activation of B-type natriuretic peptide gene via p38 mitogen-activated protein kinase and nuclear ETS factors.
###end article-title 128
###begin article-title 129
Regulation of natriuretic peptide receptor-A gene expression and stimulation of its guanylyl cyclase activity by transcription factor Ets-1.
###end article-title 129
###begin article-title 130
REST maintains self-renewal and pluripotency of embryonic stem cells.
###end article-title 130
###begin article-title 131
###xml 77 78 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
EGF stimulates proliferation of mouse embryonic stem cells: involvement of Ca2+ influx and p44/42 MAPKs.
###end article-title 131
###begin p 132
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 132
###begin p 133
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The authors have no support or funding to report.
###end p 133

